Obermatt
See Similar Stocks →

Humana

STO:HUM · SE0008040653
Health Care Providers & ServicesMedium

360

78
EV / EBIT64
Price / Owner Earnings60
Owner Earnings Yield53
Dividend Yield89
Price/Sales97
EV / Gross Profit78
Price/Book91
Return on Capital35
Cash Return on Capital44
Return on Equity35
EBIT Margin15
Gross Profitability67
Cash Conversion79
Accruals76
Owner Earnings Margin37
Sales growth48
Profit Growth35
Long-Term EPS Growth21
Owner Earnings Growth88
Reinvestment24
Price momentum83
Debt load27
Refinancing10
Debt Payback24
Liquidity39
Analyst ratings100
Opinion Changes50
Price Target Upside59
Market mood13
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Humana clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySweden
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeOM
Founded2008
Employees1,676
Websitehumana.se
ISINSE0008040653
Last UpdateApr 2, 2026
Indices
Sound Pay Practices (Europe)
Themes
Outpatient CareAssisted LivingPsychiatryHealth CareHospitalMedical

Description

Humana AB (publ) operates as a health care service provider specializing in various sectors crucial to societal well-being. The company provides tailored support primarily in three sectors, Individual & Family, Personal Assistance, and Elderly Care,…

Analysis

Middle-of-the-road

Humana AB (publ) sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

On valuation, the picture is attractive. The owner-earnings multiple stands at 9.9×; owner earnings: the cash an owner could take out each year.

Growth is solid; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

Flags to be aware of: The financial cushion is thinner than comfortable. A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
62
2023202420252026

All-time high

90

Oct 2025

All-time low

14

Aug 2024

Average rank

50

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
97
93
95
95
Price/Earnings
79
95
100
100
Price/Book
91
86
93
86
Dividend Yield
89
92
88
100
Value (overall)
100
100
100
97

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Humana with its peers
Clariane
PAR:CLARI
24
CountryFrance
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
LNA Sante
PAR:LNA
45
CountryFrance
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Bastide Le Confort Medical
PAR:BLC
64
CountryFrance
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Attendo
STO:ATT
75
CountrySweden
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
Centessa Pharmaceuticals
NSQ:CNTA
28
CountryUK
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →